Search results
Results From The WOW.Com Content Network
Cisapride is a gastroprokinetic agent, a drug that increases motility in the upper gastrointestinal tract. It acts directly as a serotonin 5-HT 4 receptor agonist and indirectly as a parasympathomimetic .
A drug recall removes a prescription or over-the-counter drug from the market. Drug recalls in the United States are made by the FDA or the creators of the drug when certain criteria are met. When a drug recall is made, the drug is removed from the market and potential legal action can be taken depending on the severity of the drug recall. [1]
This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.
CVS Health and H-E-B Baby recently issued a recall of their Premium Infant Formula with Iron Milk-Based Powder due to elevated levels of Vitamin D. Put those chips down: FDA issues recalls on at ...
Think before you drink. The FDA has recalled 28 beverages so far in 2024, The Daily Mail reported. All but four of the drinks were recalled because they had drugs, bacteria or harmful chemicals in ...
Moreover, itopride has no affinity for the 5-HT 4 receptors, unlike other benzamides such as cisapride and mosapride, which are 5-HT 4 agonists. The affinity of cisapride for 5-HT 4 receptors in the heart has been implicated in the undesirable cardiac effects of cisapride itself. [medical citation needed]
Federal food regulators raised their alarm for recalled eggs sold from Costco stores over possible salmonella exposure, reclassifying the targeted product to its highest risk level.. The FDA a ...
Dolasetron was first mentioned in the literature in 1989. [16] It is a prodrug, and most of its effects are due to its active metabolite, hydrodolasetron, which is formed in the liver by the enzyme carbonyl reductase. Dolasetron was approved by the FDA in 1997, and is also administered once daily.